PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-01-04

Date Title Company
04-Jan-2024 Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week AccessWire
04-Jan-2024 Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis AccessWire
04-Jan-2024 Recovery Delivered Expands Services to Accept Medicaid in Ohio for Online Suboxone to Treat Opioid Addiction AccessWire
04-Jan-2024 Just in Time GCP Announces Brian Guza as COO Newswire
04-Jan-2024 Just in Time GCP Announces Brian Guza as COO AccessWire
04-Jan-2024 Top 10 Tummy Tuck Surgery Questions That Women Seek Answers To AccessWire
04-Jan-2024 iTolerance, Inc. to Present at Biotech Showcase(TM) 2024 AccessWire
04-Jan-2024 Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference Formycon AG
04-Jan-2024 AMC Health Advances the Remote Management of Diabetes Through CGM Data Integration AccessWire
04-Jan-2024 Medisafe Launches Real-World "Data Pulse" Packages to Support Partners' Brand Strategy and Revenue Growth AccessWire
04-Jan-2024 No-Cost Testing Helps Bolster I-HEAL Community Wellness Day in Mississippi Delta Region AccessWire
04-Jan-2024 LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission AccessWire
04-Jan-2024 PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease PharmaKure
04-Jan-2024 Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis Vicore Pharma Holding AB (publ)
04-Jan-2024 Clearview Treatment Programs Certified by PsychArmor as a 'Veteran Ready' Organization AccessWire
04-Jan-2024 Pressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies AccessWire
04-Jan-2024 Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2 Biocomposites
04-Jan-2024 Anocca Secures GMP Manufacturing License To Push Novel KRAS TCR-T Cell Therapies Into Clinical Development Anocca AB
04-Jan-2024 2023 Novo Holdings Seed Investments Team Annual Review/Business Update Novo Holdings A/S
04-Jan-2024 Boehringer Ingelheim licenses multiple Dark Antigens® from Enara Bio to develop off-the-shelf immunotherapies for non-small cell lung cancer (NSCLC) Boehringer Ingelheim